France
BliNK Biomedical positions itself as a leader in the U.K.'s single-use medical instruments market with a commitment to innovation and customer service excellence. Established in 2014, this France-based company is significant in the Biotechnology, Life Sciences, and Pharmaceutical industries.
BliNK Biomedical boasts a pioneering past, being the first to supply single-use instruments in the U.K., and it continues to collaborate with experts in various medical fields, including ophthalmology, dermatology, and ENT, to offer advanced and personalized solutions.
The company received a €1.70M Series A investment from Eurazeo on 01 July 2016. This financial backing underlines BliNK Biomedical's potential for growth and its strategic significance in revolutionizing medical instrument supply with an emphasis on disposable, high-quality products. As they extend their market reach, their customer-focused approach and historical market leadership position them well for future investments.
